این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Cell Journal، جلد ۲۲، شماره supplement ۱، صفحات ۱۵۵-۱۶۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou
چکیده انگلیسی مقاله The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT) scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.
کلیدواژه‌های انگلیسی مقاله Anti-inflammatory Drug, Antiviral drug, COVID-19, Diagnosis, SARS-CoV-2
نویسندگان مقاله Yuping Li |
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China

Yaser Tahamtani |
Department of Diabetes, Obesity and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Mehdi Totonchi |
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Chengshui Chen |
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China

Seyed Mohammad Reza Hashemian |
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Fatemeh Amoozegar |
Noncommunicable diseases research center, Fasa University of Medical Sciences, Fasa, Iran

Jin-San Zhang |
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China

Yousef Gholampour |
Department of Internal Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran

Xiaokun Li |
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China

نشانی اینترنتی https://www.celljournal.org/article_251710_ee3289290561256211548469ab55a5ec.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات